Adagene Inc. (Nasdaq: ADAG) is a biotechnology company transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Powered by its proprietary DPL platform, composed of NEObody, SAFEbody™, and POWERbody™ technologies, Adagene’s highly differentiated pipeline features novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
View Top Employees from AdageneWebsite | http://www.adagene.com |
Ticker | ADAG |
Revenue | $10.2 million |
Funding | $295 million |
Employees | 88 (69 on RocketReach) |
Founded | 2012 |
Address | 4f Building C14 No. 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, CN |
Phone | +86 512 8777 3632 |
Technologies |
JavaScript,
HTML,
PHP
+33 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Science and Engineering, Medical, Health Care, Therapeutics |
Web Rank | 27 Million |
Keywords | Adagene, 天演药业 |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Adagene employee's phone or email?
The Adagene annual revenue was $10.2 million in 2024.
Raymond Tam is the CFO of Adagene.
69 people are employed at Adagene.
Adagene is based in Suzhou, Jiangsu.
The NAICS codes for Adagene are [541, 541714, 54171, 54, 5417].
The SIC codes for Adagene are [873, 87].